Scarica l'app Stockscreener
1.13
3.99%
-0.047
Precedente Chiudi:
$1.177
Aprire:
$1.18
Volume 24 ore:
265.80K
Relative Volume:
0.74
Capitalizzazione di mercato:
$30.75M
Reddito:
-
Utile/perdita netta:
$-13.76M
Rapporto P/E:
-1.2151
EPS:
-0.93
Flusso di cassa netto:
-
1 W Prestazione:
-3.42%
1M Prestazione:
-41.45%
6M Prestazione:
+3.67%
1 anno Prestazione:
+39.51%
Intervallo 1D:
$1.07
$1.20
Intervallo di 1 settimana:
$1.07
$1.3296
Portata 52W:
$0.6729
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
Nome
Neurosense Therapeutics Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta NRSN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
1.13 | 30.75M | 0 | -13.76M | 0 | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.33 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.84 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.60 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
662.66 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
312.09 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurosense Therapeutics Ltd Borsa (NRSN) Ultime notizie
Watch for Trend Continuation in NeuroSense Therapeutics Ltd. Next WeekJuly 2025 Big Picture & Weekly Stock Breakout Alerts - newsyoung.net
Published on: 2025-08-21 02:05:04 - thegnnews.com
NeuroSense Reports Long-Term Safety of PrimeC in ALS Study - TipRanks
Using Python tools to backtest NeuroSense Therapeutics Ltd. strategiesJuly 2025 Summary & Daily Stock Trend Reports - Newser
How to recover losses in NeuroSense Therapeutics Ltd. stockPortfolio Performance Report & Daily Volume Surge Trade Alerts - Newser
What the charts say about NeuroSense Therapeutics Ltd. todayJuly 2025 Summary & Precise Swing Trade Entry Alerts - Newser
Published on: 2025-08-20 21:29:02 - thegnnews.com
NeuroSense Therapeutics Ltd. Equity Warrant Uptrend in Early Stages Indicators Say YesMarket Growth Report & Free Fast Gain Swing Trade Alerts - beatles.ru
Published on: 2025-08-20 21:57:00 - mustnews.co.kr
Will breakout in NeuroSense Therapeutics Ltd. lead to full recoveryJuly 2025 Setups & Entry and Exit Point Strategies - Newser
Historical volatility pattern of NeuroSense Therapeutics Ltd. visualized2025 Growth vs Value & Daily Stock Trend Reports - Newser
Building trade automation scripts for NeuroSense Therapeutics Ltd. Equity Warrant2025 Support & Resistance & Daily Risk Controlled Trade Plans - Newser
Long term hold vs stop loss in NeuroSense Therapeutics Ltd.Earnings Growth Summary & Free Community Supported Trade Ideas - Newser
Real time social sentiment graph for NeuroSense Therapeutics Ltd.2025 Market Outlook & Daily Stock Momentum Reports - Newser
Does NeuroSense Therapeutics Ltd. Equity Warrant qualify in momentum factor screeningJuly 2025 Trends & Community Verified Trade Signals - Newser
Can NeuroSense Therapeutics Ltd. Equity Warrant hit a new high this monthPortfolio Risk Summary & Weekly Breakout Watchlists - Newser
Is it time to cut losses on NeuroSense Therapeutics Ltd. Equity WarrantIPO Watch & High Return Stock Watch Alerts - Newser
Reversal indicators forming on NeuroSense Therapeutics Ltd. stockJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - Newser
Measuring NeuroSense Therapeutics Ltd. Equity Warrant’s beta against major indicesQuarterly Profit Report & Accurate Technical Buy Alerts - Newser
Full technical analysis of NeuroSense Therapeutics Ltd. Equity Warrant stockJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
How sentiment analysis helps forecast NeuroSense Therapeutics Ltd.Market Growth Summary & Weekly Setup with High ROI Potential - Newser
Is NeuroSense Therapeutics Ltd. forming a bottoming baseTrade Entry Report & Consistent Profit Alerts - Newser
Risk vs reward if holding onto NeuroSense Therapeutics Ltd. Equity WarrantJuly 2025 Market Mood & Advanced Technical Analysis Signals - Newser
NeuroSense Therapeutics Ltd. stock trendline breakdownJuly 2025 Macro Moves & Accurate Intraday Trade Tips - Newser
Published on: 2025-08-19 08:13:41 - newsimpact.co.kr
NeuroSense Therapeutics Ltd.’s volatility index tracking explainedJuly 2025 Highlights & Free Real-Time Market Sentiment Alerts - Newser
NEUROSENSE THERAPEUTICS LTD. TO PARTICIPATE IN RENMARK'S VIRTUAL NON-DEAL ROADSHOW SERIES ON, TUESDAY, MARCH 21 AND TUESDAY, MARCH 28, 2023 - The Globe and Mail
What indicators show strength in NeuroSense Therapeutics Ltd.Quarterly Trade Review & Risk Adjusted Buy/Sell Alerts - Newser
Should you hold or exit NeuroSense Therapeutics Ltd. nowBreakout Watch & Free Risk Controlled Daily Trade Plans - Newser
NeuroSense Therapeutics Ltd. Pullback Analyzed — Is It Time to ExitJuly 2025 Macro Moves & Technical Confirmation Trade Alerts - sundaytimes.kr
What to expect from NeuroSense Therapeutics Ltd. Equity Warrant in the next 30 daysJuly 2025 Selloffs & Free Community Consensus Stock Picks - Newser
Pattern recognition hints at NeuroSense Therapeutics Ltd. upsideTrade Risk Summary & Safe Entry Zone Identification - Newser
What institutional flow reveals about NeuroSense Therapeutics Ltd. Equity WarrantMarket Weekly Review & Momentum Based Trading Ideas - Newser
Can NeuroSense Therapeutics Ltd. weather a recessionProfit Target & Consistent Growth Stock Picks - sundaytimes.kr
NeuroSense Therapeutics Ltd. Equity Warrant stock retracement – recovery analysisWatch List & Weekly Breakout Stock Alerts - Newser
Applying chart zones and confluence areas to NeuroSense Therapeutics Ltd. Equity Warrant2025 Market Trends & Low Risk High Win Rate Stock Picks - Newser
Is NeuroSense Therapeutics Ltd.’s ROIC above industry averageMarket Sentiment Summary & Community Consensus Trade Alerts - 선데이타임즈
Traders Consider Averaging Down in NeuroSense Therapeutics Ltd. Equity WarrantJuly 2025 Pullbacks & Capital Protection Trade Alerts - 선데이타임즈
Market reaction to NeuroSense Therapeutics Ltd.’s recent newsEarnings Growth Report & Verified Technical Signals - Newser
Published on: 2025-08-11 02:20:37 - Newser
Why NeuroSense Therapeutics Ltd. stock attracts strong analyst attentionFree Day Trading Signals With High Precision - Newser
Why NeuroSense Therapeutics Ltd. is moving todayFree Stock Screener With Smart Filters - Newser
Chart based exit strategy for NeuroSense Therapeutics Ltd.Weekly Outlook for Short Term Investors - Newser
Detecting price anomalies in NeuroSense Therapeutics Ltd. Equity Warrant with AIAlgorithmic Prediction of Market Breakouts - Newser
How hedge fund analytics apply to NeuroSense Therapeutics Ltd. stockSmart Money Strategy for Growth Stocks - Newser
NeuroSense Therapeutics Ltd. Equity Warrant Company Revenue and Profit Trends: A Deep DiveSecure Entry Point Finder with Analysis - Newser
Maxim Group Analyst Maintains Hold Rating on Neurosense Therapeutics Ltd. - AInvest
What Fibonacci levels say about NeuroSense Therapeutics Ltd. reboundReal-Time AI Generated Market Forecast - Newser
Should you wait for a breakout in NeuroSense Therapeutics Ltd.Early Buy Opportunity with Chart Triggers - Newser
Neurosense Therapeutics Ltd Azioni (NRSN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
0.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):